Get the Stockscreener App
2.0354
5.46%
0.1054
Okyo Pharma Limited stock is traded at $2.0354, with a volume of 19,608.
It is up +5.46% in the last 24 hours and down -25.17% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$1.93
Open:
$2.03
24h Volume:
19,608
Relative Volume:
0.15
Market Cap:
$76.55M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-12.41
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
+3.85%
1M Performance:
-25.17%
6M Performance:
+9.43%
1Y Performance:
+101.13%
1-Day Range:
$2.0125
$2.0963
1-Week Range:
$1.71
$2.0963
52-Week Range:
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.0354 | 75.60M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.70 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
729.43 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
462.33 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
904.45 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.81 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Okyo Pharma Limited Stock (OKYO) Latest News
What is the fair value estimate for OKYO Pharma Limited (OK11) stock in 2025Market Sentiment Report & Technical Pattern Alert System - Newser
How OKYO Pharma Limited (OK11) stock compares with top peersGlobal Markets & Long-Term Safe Investment Plans - Newser
Is OKYO Pharma Limited (OK11) stock a top pick for value investors2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Is OKYO Pharma Limited stock trading near support levelsWeekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser
Okyo Pharma chairman acquires 27,051 company shares - TipRanks
OKYO Pharma chairman-linked entity acquires additional shares on NASDAQ - Investing.com
OKYO Pharma’s Chairman Increases Stake Amidst Phase 2 Trial Completion - TipRanks
Gabriele Cerrone increases stake in OKYO Pharma with share purchase - Investing.com
OKYO Pharma Limited Executive Chairman Gabriele Cerrone Acquires Additional Shares in Company - Quiver Quantitative
Gabriele Cerrone increases stake in OKYO Pharma with share purchase By Investing.com - Investing.com UK
OKYO Pharma (NASDAQ: OKYO) chairman raises holding after buying 27,051 shares - Stock Titan
OKYO Pharma Announces Chairman and Founder Acquires Shares - Yahoo Finance Australia
Why OKYO Pharma Limited stock is a must watch in 2025Market Growth Report & Comprehensive Market Scan Reports - Newser
OKYO Pharma executive chair increases stake with additional share purchase - Proactive financial news
Holdings of OKYO Pharma Limited (OKYO) are aligned with the stars - Setenews
Decliners Report: Will OKYO Pharma Limited stock remain a Wall Street favoriteRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Panetta Partners increases stake in OKYO Pharma with purchase of 82,018 shares - Investing.com Australia
Operating cash flow per share of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Okyo Pharma chairman increases stake with new share acquisition By Investing.com - Investing.com Nigeria
OKYO Pharma stock rises after Chairman increases stake By Investing.com - Investing.com Nigeria
OKYO Pharma stock rises after Chairman increases stake - Investing.com India
OKYO Pharm Chairman and Founder acquires shares - MSN
OKYO Pharma’s Chairman Increases Stake with Recent Share Acquisition - TipRanks
Okyo Pharma chairman acquires 82,018 company shares - TipRanks
Okyo Pharma chairman increases stake with new share acquisition - Investing.com India
OKYO Pharma founder increases his buys shares - Proactive financial news
OKYO Pharma Limited Executive Chairman Acquires Additional Shares, Totaling 10.5 Million Holdings - Quiver Quantitative
Is OKYO Pharma Limited (OK11) stock trading at attractive multiples2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Why OKYO Pharma Limited (OK11) stock signals breakout potential2025 Big Picture & Fast Gaining Stock Reports - newser.com
Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight - Barchart.com
Is OKYO Pharma Limited stock oversold or undervaluedRisk Management & Stepwise Trade Signal Implementation - newser.com
Key metrics from OKYO Pharma Limited’s quarterly dataPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Why OKYO Pharma Limited stock is favored by top institutionsMarket Performance Report & Daily Stock Momentum Reports - newser.com
Has OKYO Pharma Limited found a price floorJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Will OKYO Pharma Limited stock deliver better than expected guidanceDividend Hike & AI Driven Stock Reports - newser.com
OKYO Pharma Limited stock chart pattern explainedStop Loss & Daily Stock Trend Reports - newser.com
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):